EUVIMEDEUVIMED entdecken
Fallbericht

Transplantation of Chemically triggered Pluripotent Stem cellular Derived Islets in a kind 1 Diabetes patient: A Case report and overview

Rehan Haider

Clinical Orthopaedics and Trauma Care · 25.07.2025 · 07 (02) · 01-04

DOI: 10.31579/2694-0248/133 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Orthopaedics and Trauma Care, online erschienen am 25.07.2025. Verfasst von Rehan Haider.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes mellitus (T1D) is an autoimmune disorder from discriminatory destruction of pancreatic β boxes, leading to enduring insulin deficiency and the risk of microvascular and macrovascular problems. conventional therapies, keeping exogenous insulin administration and fixed hydrogen listening to, improve glycemic management but fail to repair relevant insulin discharge. Islet transplantation from cadaveric donors has shown promise in gaining biased or partial insulin independence; nonetheless, contributor deficiency and immunological unwillingness restrict the sizeable request. Current advances in pluripotent stem cells, in particular chemically implicit pluripotent stem cells (Ci PSCs), offer a potentially unlimited source of akin insulin-significance boxes, accompanied by a reduced risk of inherited unification and tumorigenicity. Here, we file the first written dispassionate case of a 25-year-old person's associate following an 11-illness history of T1D, knowledge uphold insulin freedom following transplantation of Ci PSC-derivative islets below the stomach prior to rectus protecting. patient-spinoff oily cloth bottles have been chemically altered into Ci PSCs, exchanged into operating pancreatic restrained enclave-like clusters, and transplanted, appropriating a minimally invasive, ultrasound-inspired method. publish-flow, the patient ended extrinsic insulin ~75 days later, transplantation. continuous hydrogen tracking confirmed an area-in-variety (TIR) boom from 43.18% at well-known to >96% at 4 months and >98% via three hundred and sixty-five days, following HbA1c decline to forthcoming-sane degrees (~ five %). No circulate-following damaging incidents, containing immunological answers or cancerous lesions, had been seen at any stage of the disease. Endogenous β-container function was regularly oblique, induced C-peptide measurements, and opposing glycemic writings. This situation explains that the same Ci PSC-derivative small islet transplantation is practicable, sincere, and first-rate rate restoring long-lasting insulin discharge in T1D, presenting a capability model shift in enlightening therapy for autoimmune diabetes. Those judgments warrant exceptional, regulated, unbiased problems to choose lasting fertility, invulnerable guardianship, and extra entire pertinence of Ci PSC-positioned β-container replacement procedures.

Zitieren

APA

Haider, R. (2025). Transplantation of Chemically triggered Pluripotent Stem cellular Derived Islets in a kind 1 Diabetes patient: A Case report and overview. Clinical Orthopaedics and Trauma Care, 07(02), 01-04. https://doi.org/10.31579/2694-0248/133

Vancouver

Haider R. Transplantation of Chemically triggered Pluripotent Stem cellular Derived Islets in a kind 1 Diabetes patient: A Case report and overview. Clinical Orthopaedics and Trauma Care. 2025;07(02):01-04. doi:10.31579/2694-0248/133

BibTeX
@article{Haider2025,
  author = {Haider, Rehan},
  title = {Transplantation of Chemically triggered Pluripotent Stem cellular Derived Islets in a kind 1 Diabetes patient: A Case report and overview},
  journal = {Clinical Orthopaedics and Trauma Care},
  year = {2025},
  volume = {07},
  number = {02},
  pages = {01--04},
  doi = {10.31579/2694-0248/133}
}
Kostenlos starten →